Tufts University School of Medicine’s Biopharma Program, is designed specifically to enhance career options through intensive training in disciplines that contribute to the development and regulation of human pharmaceuticals and medical devices. This specialized program meets a critical need for structured, educational opportunities that have a focus on the fundamental concepts of therapeutic product development.
The Tufts Biopharma Program’s academic offerings include a Master of Science degree track and a Certificate track. Both tracks are tailored to the needs of working professionals who want to attend classes on a part-time basis in the evening. The MS track consists of twelve credits to be completed over two academic years, and includes didactic coursework as well as an experiential capstone project. The five-credit Certificate track is a twelve-month program comprised of core discipline courses taken in lock-step with the MS degree track.
The Tufts Biopharma Program is closely aligned with the Tufts Center for the Study of Drug Development (CSDD), an internationally recognized and renowned academic center that develops and provides strategic information to help developers, regulators, and policy makers improve the efficiency and productivity of biomedical innovation.
Tufts University School of Medicine is the ideal location to study and work towards a career in the biopharma industry. The Boston and Cambridge metropolitan area surrounding the campus forms a unique life sciences “super cluster” containing numerous pharmaceutical, biotechnology, device, and diagnostics companies, which are nestled among top-ranked academic centers, teaching hospitals, contract services organizations, and investment firms.